Rxsight Inc RXST
$6.01
▼ -1.15%
($-0.07)
📅 Earnings This Week
Open
$6.08
Prev Close
$6.08
Day Range
$5.86 – $6.12
52W Range
$4.48 – $13.22
Market Cap
$248.79M
Beta
1.13
EPS (TTM)
$-1.14
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-30 |
| Shares Out. | 41,400,000 |
| Website | rxsight.com/ ↗ |
| Phone | 13026587581 |
| Employees | 461 |
| Revenue | $30.9M |
| Gross Profit | $23.5M |
| Net Income | -$15.9M |
| Free Cash Flow | -$21.6M |
| Total Assets | $304.0M |
| Total Liabilities | $36.7M |
| Equity | $267.3M |
About Rxsight Inc
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Rxsight Inc is a publicly traded company under the ticker symbol RXST on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-07-01)